# The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy

> **NCT03627130** · PHASE2 · COMPLETED · sponsor: **Barts & The London NHS Trust** · enrollment: 640 (actual)

## Conditions studied

- Contrast-induced Nephropathy
- Acute Kidney Injury
- Acute Coronary Syndrome

## Interventions

- **DRUG:** Potassium Nitrate
- **DRUG:** Potassium Chloride

## Key facts

- **NCT ID:** NCT03627130
- **Lead sponsor:** Barts & The London NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-29
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 640 (ACTUAL)
- **Last updated:** 2022-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03627130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03627130, "The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03627130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*